Alexandria Real Estate Equities
ARE
#2394
Rank
C$11.14 B
Marketcap
C$64.00
Share price
0.49%
Change (1 day)
-15.90%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): C$1.87

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is C-$12.00. In 2022 the company made an earnings per share (EPS) of C$4.46 a decrease over its 2021 EPS that were of C$5.40.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$1.87-58.12%
2022C$4.46-17.41%
2021C$5.40-35.32%
2020C$8.3589.03%
2019C$4.42-12.68%
2018C$5.06124.68%
2017C$2.25-179%
2016C-$2.85-221.95%
2015C$2.3462.38%
2014C$1.44-36.87%
2013C$2.2846.79%
2012C$1.55-36.63%
2011C$2.45-20.74%
2010C$3.09-21.66%
2009C$3.95-3.48%
2008C$4.098.3%
2007C$3.7816.23%
2006C$3.250.88%
2005C$3.22-9.27%
2004C$3.55-23.36%
2003C$4.6381.56%
2002C$2.557.19%
2001C$2.38-7.22%
2000C$2.5621.62%
1999C$2.11-8.07%
1998C$2.29-217.81%
1997C-$1.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.01-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.01-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.76-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.42-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$8.39-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.44-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$28.22-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA